Eishun Tsuchida
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Eishun Tsuchida has a total of 178 co-authors. Here are the top co-authors by number of shared publications:
- Hiroyuki Nishide
Department of Polymer Chemistry, Waseda University, Tokyo 169‐8555, Japan
56 shared publications Shinji Takeoka
Research Institute for Science and Engineering, Graduate School of Advanced Science and Engineering, and Consolidated Research Institute for Advanced Science and Medical Care, Waseda University, Tokyo 169-8555, Japan
24 shared publications- Hiromi Sakai
Nara Medical University
22 shared publications - Teruyuki Komatsu
Department of Applied Chemistry, Faculty of Science and Engineering, Chuo University
20 shared publications Kimihisa Yamamoto
Advanced Research Institute for Science and Engineering, Department of Polymer Chemistry, Waseda University
18 shared publicationsKoichi Kobayashi
Department of Surgery, School of Medicine, Keio University, Shinjuku, Tokyo, Japan
13 shared publications
Latest Publications
- 4 July 2011
- Published by Wiley
- p. 381-390
Hemoglobin Vesicles as a Cellular‐Type Hemoglobin‐Based Oxygen Carrier
- 4 July 2011
- Published by Wiley
- p. 381-390
Hemoglobin Vesicles as a Cellular‐Type Hemoglobin‐Based Oxygen Carrier
- 2 July 2009
- Published by American Chemical Society (ACS) in Biomacromolecules
- Vol. 10 (8) , 2344-2350
Mechanism of Flocculate Formation of Highly Concentrated Phospholipid Vesicles Suspended in a Series of Water-Soluble Biopolymers
Polyethylene glycol-modified vesicles (liposomes) encapsulating hemoglobin (HbV) are artificial oxygen carriers that have been developed as a transfusion alternative. The HbV suspension in an albumin solution is nearly Newtonian; other biopolymers, hydroxyethyl starch (HES), dextran (DEX), and modified fluid gelatin, induce flocculation of HbVs through depletion interaction and render the suspensions as non-Newtonian. The flocculation level increased with hydrodynamic radius (Rh) or radius of gyration (Rg) of series of HES or DEX with different molecular weights at a constant polymer concentration (4 wt %). However, the flocculation level differed markedly among the polymers. A crowding index (Ci) representing the crowding level of a polymer solution is defined as (excluded volume of one polymer) × (molar concentration) × Avogadro’s number, using Rh or Rg. All polymers’ flocculation level increases when Ci approaches 1: when the theoretical total excluded volumes approach the entire solution volume, the excluded HbV particles are forced to flocculate.
- 2 July 2009
- Published by American Chemical Society (ACS) in Biomacromolecules
- Vol. 10 (8) , 2344-2350
Mechanism of Flocculate Formation of Highly Concentrated Phospholipid Vesicles Suspended in a Series of Water-Soluble Biopolymers
Polyethylene glycol-modified vesicles (liposomes) encapsulating hemoglobin (HbV) are artificial oxygen carriers that have been developed as a transfusion alternative. The HbV suspension in an albumin solution is nearly Newtonian; other biopolymers, hydroxyethyl starch (HES), dextran (DEX), and modified fluid gelatin, induce flocculation of HbVs through depletion interaction and render the suspensions as non-Newtonian. The flocculation level increased with hydrodynamic radius (Rh) or radius of gyration (Rg) of series of HES or DEX with different molecular weights at a constant polymer concentration (4 wt %). However, the flocculation level differed markedly among the polymers. A crowding index (Ci) representing the crowding level of a polymer solution is defined as (excluded volume of one polymer) × (molar concentration) × Avogadro’s number, using Rh or Rg. All polymers’ flocculation level increases when Ci approaches 1: when the theoretical total excluded volumes approach the entire solution volume, the excluded HbV particles are forced to flocculate.
- 26 May 2009
- Published by American Chemical Society (ACS) in The Journal of Physical Chemistry B
- Vol. 113 (24) , 8418-8428
Static Structures and Dynamics of Hemoglobin Vesicle (HbV) Developed as a Transfusion Alternative
Hemoglobin vesicle (HbV) is an artificial oxygen carrier that encapsulates solution of purified and highly concentrated (ca. 38 g dL−1) human hemoglobin. Its exceptionally high concentration as a liposomal product (ca. 40% volume fraction) achieves an oxygen-carrying capacity comparable to that of blood. We use small-angle X-ray scattering (SAXS) and dynamic light scattering (DLS) to investigate the hierarchical structures and dynamics of HbVs in concentrated suspensions. SAXS data revealed unilamellar shell structure and internal density profile of the artificial cell membrane for Hb encapsulation. The SAXS intensity of HbV at scattering vector q > 0.5 nm−1 manifests dissolution states of the encapsulated Hbs in the inner aqueous phase of the vesicle having ca. 240 nm diameter. The peak position as well as the height and width of static structure factor of Hb before and after encapsulation are almost identical, demonstrating the preserved protein−protein interactions in the confined space. To overcome multiple scattering from turbid samples, we employed thin layer-cell DLS combined with the so-called bruteforce and echo techniques, which allows us to observe collective diffusion dynamics of HbVs without dilution. A pronounced slowdown of the HbV diffusion and eventual emergence of dynamically arrested state in the presence of high-concentration plasma substitutes (water-soluble polymers), such as dextran, modified fluid gelatin, and hydroxylethyl starch, can be explained by depletion interaction. A significantly weaker effect of recombinant human serum albumin on HbV flocculation and viscosity enhancement than those induced by other polymers is clearly attributed to the specificity as a protein; its compact structure efficiently reduces the reservoir polymer volume fraction that determines the depth of the attractive potential between HbVs. These phenomena are technically essential for controlling the suspension rheology, which is advantageous for versatile clinical applications.
- 26 May 2009
- Published by American Chemical Society (ACS) in The Journal of Physical Chemistry B
- Vol. 113 (24) , 8418-8428
Static Structures and Dynamics of Hemoglobin Vesicle (HbV) Developed as a Transfusion Alternative
Hemoglobin vesicle (HbV) is an artificial oxygen carrier that encapsulates solution of purified and highly concentrated (ca. 38 g dL−1) human hemoglobin. Its exceptionally high concentration as a liposomal product (ca. 40% volume fraction) achieves an oxygen-carrying capacity comparable to that of blood. We use small-angle X-ray scattering (SAXS) and dynamic light scattering (DLS) to investigate the hierarchical structures and dynamics of HbVs in concentrated suspensions. SAXS data revealed unilamellar shell structure and internal density profile of the artificial cell membrane for Hb encapsulation. The SAXS intensity of HbV at scattering vector q > 0.5 nm−1 manifests dissolution states of the encapsulated Hbs in the inner aqueous phase of the vesicle having ca. 240 nm diameter. The peak position as well as the height and width of static structure factor of Hb before and after encapsulation are almost identical, demonstrating the preserved protein−protein interactions in the confined space. To overcome multiple scattering from turbid samples, we employed thin layer-cell DLS combined with the so-called bruteforce and echo techniques, which allows us to observe collective diffusion dynamics of HbVs without dilution. A pronounced slowdown of the HbV diffusion and eventual emergence of dynamically arrested state in the presence of high-concentration plasma substitutes (water-soluble polymers), such as dextran, modified fluid gelatin, and hydroxylethyl starch, can be explained by depletion interaction. A significantly weaker effect of recombinant human serum albumin on HbV flocculation and viscosity enhancement than those induced by other polymers is clearly attributed to the specificity as a protein; its compact structure efficiently reduces the reservoir polymer volume fraction that determines the depth of the attractive potential between HbVs. These phenomena are technically essential for controlling the suspension rheology, which is advantageous for versatile clinical applications.
- 10 February 2009
- Published by American Chemical Society (ACS) in Bioconjugate Chemistry
- Vol. 20 (8) , 1419-1440
Artificial Oxygen Carriers, Hemoglobin Vesicles and Albumin−Hemes, Based on Bioconjugate Chemistry
Hemoglobin (Hb, Mw: 64 500) and albumin (Mw: 66 500) are major protein components in our circulatory system. On the basis of bioconjugate chemistry of these proteins, we have synthesized artificial O2 carriers of two types, which will be useful as transfusion alternatives in clinical situations. Along with sufficient O2 transporting capability, they show no pathogen, no blood type antigen, biocompatibility, stability, capability for long-term storage, and prompt degradation in vivo. Herein, we present the latest results from our research on these artificial O2 carriers, Hb-vesicles (HbV) and albumin−hemes. (i) HbV is a cellular type Hb-based O2 carrier. Phospholipid vesicles (liposomes, 250 nm diameter) encapsulate highly purified and concentrated human Hb (35 g/dL) to mimic the red blood cell (RBC) structure and eliminate side effects of molecular Hb such as vasoconstriction. The particle surface is modified with PEG-conjugated phospholipids, thereby improving blood compatibility and dispersion stability. Manipulation of physicochemical parameters of HbV, such as O2 binding affinity and suspension rheology, supports the use of HbV for versatile medical applications. (ii) Human serum albumin (HSA) incorporates synthetic Fe2+porphyrin (FeP) to yield unique albumin-based O2 carriers. Changing the chemical structure of incorporated FeP controls O2 binding parameters. In fact, PEG-modified HSA-FeP showed good blood compatibility and O2 transport in vivo. Furthermore, the genetically engineered heme pocket in HSA can confer O2 binding ability to the incorporated natural Fe2+protoporphyrin IX (heme). The O2 binding affinity of the recombinant HSA (rHSA)-heme is adjusted to a similar value to that of RBC through optimization of the amino acid residues around the coordinated O2.
- 10 February 2009
- Published by American Chemical Society (ACS) in Bioconjugate Chemistry
- Vol. 20 (8) , 1419-1440
Artificial Oxygen Carriers, Hemoglobin Vesicles and Albumin−Hemes, Based on Bioconjugate Chemistry
Hemoglobin (Hb, Mw: 64 500) and albumin (Mw: 66 500) are major protein components in our circulatory system. On the basis of bioconjugate chemistry of these proteins, we have synthesized artificial O2 carriers of two types, which will be useful as transfusion alternatives in clinical situations. Along with sufficient O2 transporting capability, they show no pathogen, no blood type antigen, biocompatibility, stability, capability for long-term storage, and prompt degradation in vivo. Herein, we present the latest results from our research on these artificial O2 carriers, Hb-vesicles (HbV) and albumin−hemes. (i) HbV is a cellular type Hb-based O2 carrier. Phospholipid vesicles (liposomes, 250 nm diameter) encapsulate highly purified and concentrated human Hb (35 g/dL) to mimic the red blood cell (RBC) structure and eliminate side effects of molecular Hb such as vasoconstriction. The particle surface is modified with PEG-conjugated phospholipids, thereby improving blood compatibility and dispersion stability. Manipulation of physicochemical parameters of HbV, such as O2 binding affinity and suspension rheology, supports the use of HbV for versatile medical applications. (ii) Human serum albumin (HSA) incorporates synthetic Fe2+porphyrin (FeP) to yield unique albumin-based O2 carriers. Changing the chemical structure of incorporated FeP controls O2 binding parameters. In fact, PEG-modified HSA-FeP showed good blood compatibility and O2 transport in vivo. Furthermore, the genetically engineered heme pocket in HSA can confer O2 binding ability to the incorporated natural Fe2+protoporphyrin IX (heme). The O2 binding affinity of the recombinant HSA (rHSA)-heme is adjusted to a similar value to that of RBC through optimization of the amino acid residues around the coordinated O2.
- 23 January 2009
- Published by Wiley in Artificial Organs
- Vol. 33 (2) , 139-145
Review of Hemoglobin‐Vesicles as Artificial Oxygen Carriers
Blood transfusion systems have greatly benefited human health and welfare. Nevertheless, some problems remain: infection, blood type mismatching, immunological response, short shelf life, and screening test costs. Blood substitutes have been under development for decades to overcome such problems. Plasma component substitutes have already been established: plasma expanders, electrolytes, and recombinant coagulant factors. Herein, we focus on the development of red blood cell (RBC) substitutes. Side effects hindered early development of cell‐free hemoglobin (Hb)‐based oxygen carriers (HBOCs) and underscored the physiological importance of the cellular structure of RBCs. Well‐designed artificial oxygen carriers that meet requisite criteria are expected to be realized eventually. Encapsulation of Hb is one idea to shield the toxicities of molecular Hbs. However, intrinsic issues of encapsulated Hbs must be resolved: difficulties related to regulating the molecular assembly, and management of its physicochemical and biochemical properties. Hb‐vesicles (HbV) are a cellular type of HBOC that overcome these issues. The in vivo safety and efficacy of HbV have been studied extensively. The results illustrate the potential of HbV as a transfusion alternative and promise its use for other clinical applications that remain unattainable using RBC transfusion.
- 23 January 2009
- Published by Wiley in Artificial Organs
- Vol. 33 (2) , 139-145
Review of Hemoglobin‐Vesicles as Artificial Oxygen Carriers
Blood transfusion systems have greatly benefited human health and welfare. Nevertheless, some problems remain: infection, blood type mismatching, immunological response, short shelf life, and screening test costs. Blood substitutes have been under development for decades to overcome such problems. Plasma component substitutes have already been established: plasma expanders, electrolytes, and recombinant coagulant factors. Herein, we focus on the development of red blood cell (RBC) substitutes. Side effects hindered early development of cell‐free hemoglobin (Hb)‐based oxygen carriers (HBOCs) and underscored the physiological importance of the cellular structure of RBCs. Well‐designed artificial oxygen carriers that meet requisite criteria are expected to be realized eventually. Encapsulation of Hb is one idea to shield the toxicities of molecular Hbs. However, intrinsic issues of encapsulated Hbs must be resolved: difficulties related to regulating the molecular assembly, and management of its physicochemical and biochemical properties. Hb‐vesicles (HbV) are a cellular type of HBOC that overcome these issues. The in vivo safety and efficacy of HbV have been studied extensively. The results illustrate the potential of HbV as a transfusion alternative and promise its use for other clinical applications that remain unattainable using RBC transfusion.
- 10 November 2008
- Published by Wiley in Chemistry – A European Journal
- Vol. 14 (33) , 10303-10308
Protein Nanotubes Comprised of an Alternate Layer‐by‐Layer Assembly Using a Polycation as an Electrostatic Glue
We present the synthesis and structure of various protein nanotubes comprised of an alternate layer‐by‐layer (LbL) assembly using a polycation as an electrostatic glue. The nanotubes were fabricated by sequential LbL depositions of positively charged polycations and negatively charged proteins into a porous polycarbonate (PC) membrane, followed by release of the cylindrical core by quick dissolution of the template with CH2Cl2. This procedure provides a variety of protein nanotubes without interlayer cross‐linking. The three‐cycle depositions of poly‐L‐arginine (PLA) and human serum albumin (HSA, Mw=66.5 kDa) into the porous PC template (pore diameter, Dp=400 nm) yielded well‐defined (PLA/HSA)3 nanotubes with an outer diameter of 419±29 nm and a wall thickness of 46±8 nm, revealed by scanning electron microscopy (SEM) and transmission electron microscopy (TEM) observations. The outer diameter of the tubules can be controlled by the pore size of the template (200–800 nm), whereas the wall thickness is always constant, independent of the Dp value. The (PEI/HSA)3 (PEI: polyethylenimine) nanotubes showed a slightly thin wall of 39±5 nm. CD spectra of the multilayered (PEI/HSA)n film on a flat quartz plate suggested that the secondary structure of HSA between the polycations was almost the same as that in aqueous solution. The three‐cycle LbL depositions of PLA and ferritin (Mw=460 kDa) or myoglobin (Mb, Mw=1.7 kDa) into the porous PC membrane also gave cylindrical hollow structures. The wall thickness of the (PLA/ferritin)3 and (PLA/Mb)3 nanotubes were 55±5 nm and 31±4 nm; it depends on the globular size of the protein (ferritin>HSA>Mb). The individual ferritin molecule was clearly seen in the tubular walls by SEM and TEM measurements.
- 10 November 2008
- Published by Wiley in Chemistry – A European Journal
- Vol. 14 (33) , 10303-10308
Protein Nanotubes Comprised of an Alternate Layer‐by‐Layer Assembly Using a Polycation as an Electrostatic Glue
We present the synthesis and structure of various protein nanotubes comprised of an alternate layer‐by‐layer (LbL) assembly using a polycation as an electrostatic glue. The nanotubes were fabricated by sequential LbL depositions of positively charged polycations and negatively charged proteins into a porous polycarbonate (PC) membrane, followed by release of the cylindrical core by quick dissolution of the template with CH2Cl2. This procedure provides a variety of protein nanotubes without interlayer cross‐linking. The three‐cycle depositions of poly‐L‐arginine (PLA) and human serum albumin (HSA, Mw=66.5 kDa) into the porous PC template (pore diameter, Dp=400 nm) yielded well‐defined (PLA/HSA)3 nanotubes with an outer diameter of 419±29 nm and a wall thickness of 46±8 nm, revealed by scanning electron microscopy (SEM) and transmission electron microscopy (TEM) observations. The outer diameter of the tubules can be controlled by the pore size of the template (200–800 nm), whereas the wall thickness is always constant, independent of the Dp value. The (PEI/HSA)3 (PEI: polyethylenimine) nanotubes showed a slightly thin wall of 39±5 nm. CD spectra of the multilayered (PEI/HSA)n film on a flat quartz plate suggested that the secondary structure of HSA between the polycations was almost the same as that in aqueous solution. The three‐cycle LbL depositions of PLA and ferritin (Mw=460 kDa) or myoglobin (Mb, Mw=1.7 kDa) into the porous PC membrane also gave cylindrical hollow structures. The wall thickness of the (PLA/ferritin)3 and (PLA/Mb)3 nanotubes were 55±5 nm and 31±4 nm; it depends on the globular size of the protein (ferritin>HSA>Mb). The individual ferritin molecule was clearly seen in the tubular walls by SEM and TEM measurements.
- 22 July 2008
- Published by American Chemical Society (ACS) in Bioconjugate Chemistry
- Vol. 19 (8) , 1556-1560
Structure, Photophysical Property, and Cytotoxicity of Human Serum Albumin Complexed with Tris(dicarboxymethylene)[60]fullerene
We present structure, photoexcited triplet-state property, and singlet oxygen (1O2) generation capability of human serum albumin complexed with a tris(dicarboxymethylene)[60]fullerene C3-isomer (HSA−CF). Small angle X-ray scattering measurements showed that a globular size-dimension and surface charge distribution of HSA were unaltered by monomolecular complexation of CF into the hydrophobic cavity. Laser flash photolysis to the HSA−CF solution yielded a photoexcited triplet state of the CF chromophore (3CF*) with lifetime of 46 μs. In the presence of O2, energy transfer occurred from HSA−3CF* to O2 to generate 1O2; the quenching rate constant [kq(O2)] was determined to be 2.2 × 108 M−1 s−1. The HSA−CF showed strong photoresistence relative to HSA complexed with a protoporphyrin IX. The quantum yield of 1O2 production for this artificial protein was compared to those of other photosensitizing agent. The HSA−CF did not show a dark cytotoxicity, but induced cell death efficiently under visible light irradiation.
- 22 July 2008
- Published by American Chemical Society (ACS) in Bioconjugate Chemistry
- Vol. 19 (8) , 1556-1560
Structure, Photophysical Property, and Cytotoxicity of Human Serum Albumin Complexed with Tris(dicarboxymethylene)[60]fullerene
We present structure, photoexcited triplet-state property, and singlet oxygen (1O2) generation capability of human serum albumin complexed with a tris(dicarboxymethylene)[60]fullerene C3-isomer (HSA−CF). Small angle X-ray scattering measurements showed that a globular size-dimension and surface charge distribution of HSA were unaltered by monomolecular complexation of CF into the hydrophobic cavity. Laser flash photolysis to the HSA−CF solution yielded a photoexcited triplet state of the CF chromophore (3CF*) with lifetime of 46 μs. In the presence of O2, energy transfer occurred from HSA−3CF* to O2 to generate 1O2; the quenching rate constant [kq(O2)] was determined to be 2.2 × 108 M−1 s−1. The HSA−CF showed strong photoresistence relative to HSA complexed with a protoporphyrin IX. The quantum yield of 1O2 production for this artificial protein was compared to those of other photosensitizing agent. The HSA−CF did not show a dark cytotoxicity, but induced cell death efficiently under visible light irradiation.
- Open Access
- 27 November 2007
- Published by Wiley in Journal of Internal Medicine
- Vol. 263 (1) , 4-15
Haemoglobin‐vesicles as artificial oxygen carriers: present situation and future visions
: During the long history of development of haemoglobin (Hb)‐based O2 carriers (HBOCs), many side effects of Hb molecules have become apparent. They imply the physiological importance of the cellular structure of red blood cells. Hb‐vesicles (HbV) are artificial O2 carriers that encapsulate concentrated Hb solution with a thin lipid membrane. We have overcome the intrinsic issues of the suspension of HbV as a molecular assembly, such as stability for storage and in blood circulation, blood compatibility and prompt degradation in the reticuloendothelial system. Animal tests clarified the efficacy of HbV as a transfusion alternative and the possibility for other clinical applications. The results of ongoing HbV research make us confident in advancing further development of HbV, with the expectation of its eventual realization.
- 27 November 2007
- Published by Wiley in Journal of Internal Medicine
- Vol. 263 (1) , 4-15
Open AccessHaemoglobin‐vesicles as artificial oxygen carriers: present situation and future visions
: During the long history of development of haemoglobin (Hb)‐based O2 carriers (HBOCs), many side effects of Hb molecules have become apparent. They imply the physiological importance of the cellular structure of red blood cells. Hb‐vesicles (HbV) are artificial O2 carriers that encapsulate concentrated Hb solution with a thin lipid membrane. We have overcome the intrinsic issues of the suspension of HbV as a molecular assembly, such as stability for storage and in blood circulation, blood compatibility and prompt degradation in the reticuloendothelial system. Animal tests clarified the efficacy of HbV as a transfusion alternative and the possibility for other clinical applications. The results of ongoing HbV research make us confident in advancing further development of HbV, with the expectation of its eventual realization.
- 15 May 2007
- Published by American Physical Society (APS) in Physical Review Letters
- Vol. 98 (20) , 208101
Induced Long-Range Attractive Potentials of Human Serum Albumin by Ligand Binding
Small-angle x-ray scattering and dielectric spectroscopy investigation on the solutions of recombinant human serum albumin and its heme hybrid revealed that heme incorporation induces a specific long-range attractive potential between protein molecules. This is evidenced by the enhanced forward intensity upon heme binding, despite no hindrance to rotatory Brownian motion, unbiased colloid osmotic pressure, and discontiguous nearest-neighbor distance, confirming monodispersity of the proteins. The heme-induced potential may play a trigger role in recognition of the ligand-filled human serum albumins in the circulatory system.
- 15 May 2007
- Published by American Physical Society (APS) in Physical Review Letters
- Vol. 98 (20) , 208101
Induced Long-Range Attractive Potentials of Human Serum Albumin by Ligand Binding
Small-angle x-ray scattering and dielectric spectroscopy investigation on the solutions of recombinant human serum albumin and its heme hybrid revealed that heme incorporation induces a specific long-range attractive potential between protein molecules. This is evidenced by the enhanced forward intensity upon heme binding, despite no hindrance to rotatory Brownian motion, unbiased colloid osmotic pressure, and discontiguous nearest-neighbor distance, confirming monodispersity of the proteins. The heme-induced potential may play a trigger role in recognition of the ligand-filled human serum albumins in the circulatory system.